Diagnostics Firms Poised To Gain From Innovation Tax Credit Program
This article was originally published in The Gray Sheet
Executive Summary
Diagnostics firms stand to benefit most among medical device companies from $1 billion in life sciences innovation tax credits approved earlier this year, according to AdvaMed